| Full text | |
| Author(s): |
da Fonseca, Elize Massard
Total Authors: 1
|
| Document type: | Journal article |
| Source: | GLOBAL PUBLIC HEALTH; v. 13, n. 4, p. 489-502, 2018. |
| Web of Science Citations: | 5 |
| Abstract | |
The global health community is increasingly advocating for the local production of pharmaceuticals in developing countries as a way to promote technology transfer, capacity building and improve access to medicines. However, efforts to advance drug manufacturing in these countries revive an old dilemma of fostering technological development versus granting access to social services, such as healthcare. This paper explores the case of Brazil, a country that has developed large-scale health-inspired industrial policies, but is, yet, little understood. Brazil's experience suggests that progressive healthcare bureaucrats can create innovative practices for technology and knowledge transfers. It also demonstrates that highly competitive pharmaceutical firms can collaborate with each other, if a government provides them the right incentives. Reforming regulatory policies is crucial for guaranteeing high-quality products in developing countries, but governments must play a crucial role in supporting local firms to adapt to these regulations. These findings send a strong message to global health policymakers and practitioners on the conditions to create a suitable environment for local production of medical products. (AU) | |
| FAPESP's process: | 15/18604-5 - Policies to increase the competitiveness of the pharmaceutical sector: Brazil's experience |
| Grantee: | Elize Massard da Fonseca |
| Support Opportunities: | Research Grants - Young Investigators Grants |
| FAPESP's process: | 14/07725-3 - Industrial policy and medicines in Brazil: state, markets and sectoral arrangement |
| Grantee: | Elize Massard da Fonseca |
| Support Opportunities: | Scholarships in Brazil - Post-Doctoral |